Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001938516 | SCV002197071 | pathogenic | Congenital myasthenic syndrome 4A | 2022-11-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1417628). This variant is also known as c.787C>T (p.Gln263X). This premature translational stop signal has been observed in individual(s) with clinical features of congenital myasthenic syndrome (PMID: 22678886). This variant is present in population databases (rs773929089, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Gln283*) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). |
Fulgent Genetics, |
RCV002491896 | SCV002799504 | likely pathogenic | Congenital myasthenic syndrome 4A; Congenital myasthenic syndrome 4C; Congenital myasthenic syndrome 4B | 2022-02-18 | criteria provided, single submitter | clinical testing |